Showing results (21-30 of 43) with videos related to

Sort By:
Pageof 5
Immunology and Allergy Clinics of North America|May 12, 2007
Biphasic anaphylaxis: review of incidence, clinical predictors, and observation recommendationsJohn W Tole, Phil Lieberman
Future Cardiology|August 9, 2012
Aspirin sensitivity and coronary artery disease: implications for the practicing cardiologistDebendra Pattanaik, Phil Lieberman, Pranab Das
Current Medical Research and Opinion|May 19, 2005
Open-label evaluation of azelastine nasal spray in patients with seasonal allergic rhinitis and nonallergic vasomotor rhinitisPhil Lieberman, Michael A Kaliner, William J Wheeler
The World Allergy Organization Journal|December 5, 2015
Risk multipliers for severe food anaphylaxisPeter K Smith, Jonathan O'B Hourihane, Phil Lieberman
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|August 3, 2018
The changing face of anaphylaxis in adults and adolescentsDebendra Pattanaik, Phil Lieberman, Jay Lieberman, et al.
Allergy and Asthma Proceedings|December 22, 2020
Ideal body position for epinephrine autoinjector administrationQing Wang, Luke Pittman, Andrew Healey, et al.
Allergy and Asthma Proceedings|March 9, 2021
Ideal body position for epinephrine autoinjector administrationQing Wang, Luke Pittman, Andrew Healey, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|September 13, 2019
Idiopathic anaphylaxis yardstick: Practical recommendations for clinical practiceMelody C Carter, Cem Akin, Mariana C Castells, et al.
Allergy and Asthma Proceedings|March 1, 2011
Two-week comparison study of olopatadine hydrochloride nasal spray 0.6% versus azelastine hydrochloride nasal spray 0.1% in patients with vasomotor rhinitisPhil Lieberman, Eli O Meltzer, Craig F LaForce, et al.
The Journal of Allergy and Clinical Immunology. in Practice|March 11, 2014
Long-term, randomized safety study of MP29-02 (a novel intranasal formulation of azelastine hydrochloride and fluticasone propionate in an advanced delivery system) in subjects with chronic rhinitisWilliam E Berger, Shailen Shah, Phil Lieberman, et al.
Pageof 5